Article
Epigenetic dysregulation in glioblastoma: potential pathways to precision medicine.
Neurogenetics - 25 Nov 2024
Prakash Vijeta, Gabrani Reema
Abstract excerpt
The emerging field of epigenetics has been driving glioblastoma multiforme (GBM) development and progression. Various epigenetic alterations involving tumor suppressor genes, oncogenes, and signaling pathways have been identified in GBM. These alterations contribute to the aggressive behavior, therapeutic resistance, and tumor heterogeneity observed in GBM. Furthermore, the identification of specific genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
